BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. and managed by BlackRock Advisors, LLC. It invests in U.S. public equity markets, focusing on companies in the health sciences and related sectors, including those involved in researching, developing, producing, distributing, or delivering medical, dental, optical, pharmaceutical, or biotechnology products, supplies, equipment, or services. The fund also uses equity derivatives, with an emphasis on option writing, and benchmarks its performance against the Russell 3000 Healthcare Index. Formed on March 31, 2005, it is domiciled in the United States.